Cormedix (STU:19KA) Beginning Cash Position : €37.70 Mil (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Cormedix Beginning Cash Position?

Cormedix's Beginning Cash Position for the quarter that ended in Mar. 2025 was €37.70 Mil.

Cormedix's quarterly Beginning Cash Position increased from Sep. 2024 (€25.81 Mil) to Dec. 2024 (€33.80 Mil) and increased from Dec. 2024 (€33.80 Mil) to Mar. 2025 (€37.70 Mil).

Cormedix's annual Beginning Cash Position declined from Dec. 2022 (€50.55 Mil) to Dec. 2023 (€39.77 Mil) but then increased from Dec. 2023 (€39.77 Mil) to Dec. 2024 (€41.85 Mil).

Cormedix Beginning Cash Position Historical Data

The historical data trend for Cormedix's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cormedix Beginning Cash Position Chart

Cormedix Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Beginning Cash Position

Get a 7-Day Free Trial

13.59

37.26

50.55

39.77

41.85

Cormedix Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Beginning Cash Position	Get a 7-Day Free Trial															40.32	32.85	25.81	33.80	37.70

Cormedix Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Cormedix Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Cormedix's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Cormedix Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cormedix Inc (STU:19KA) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

CRMD:USA

Address

300 Connell Drive, Suite 4200, Berkeley Heights, NJ, USA, 07922

Website

https://www.cormedix.com

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Cormedix Headlines

No Headlines